Cargando…
Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities
Due to the speed, efficiency, relative risk, and lower costs compared to traditional drug discovery, the prioritization of candidate drugs for repurposing against cancers of interest has attracted the attention of experts in recent years. Herein, we present a powerful computational approach, termed...
Autores principales: | Di, Jieyi, Zheng, Baotong, Kong, Qingfei, Jiang, Ying, Liu, Siyao, Yang, Yang, Han, Xudong, Sheng, Yuqi, Zhang, Yunpeng, Cheng, Liang, Han, Junwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763777/ https://www.ncbi.nlm.nih.gov/pubmed/31408580 http://dx.doi.org/10.1002/1878-0261.12564 |
Ejemplares similares
-
Identification of Cancer Dysfunctional Subpathways by Integrating DNA Methylation, Copy Number Variation, and Gene-Expression Data
por: Liu, Siyao, et al.
Publicado: (2019) -
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019) -
Inference of patient‐specific subpathway activities reveals a functional signature associated with the prognosis of patients with breast cancer
por: Han, Junwei, et al.
Publicado: (2018) -
Ontology-based identification and prioritization of candidate drugs for epilepsy from literature
por: Müller, Bernd, et al.
Publicado: (2022) -
DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19
por: Su, Yinchun, et al.
Publicado: (2023)